Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Post-Marketing, Non-Interventional, Observational Study to Evaluate Persistence to Tocilizumab SC as Monotherapy or in Combination With cDMARD Treatment in RA Patients in Greece: the EMBRACE-SC Study.

NCT02648035 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02648035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02648035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Post-Marketing, Non-Interventional, Observational Study to Evaluate Persistence to Tocilizumab SC as Monotherapy or in Combination With cDMARD Treatment in RA Patients in Greece: the EMBRACE-SC Study.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
September 22, 2016
Completion date
December 20, 2018
Enrollment
200 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis